M
Marco Miglionico
Researcher at Università Campus Bio-Medico
Publications - 16
Citations - 758
Marco Miglionico is an academic researcher from Università Campus Bio-Medico. The author has contributed to research in topics: Percutaneous coronary intervention & Atorvastatin. The author has an hindex of 6, co-authored 16 publications receiving 705 citations.
Papers
More filters
Journal ArticleDOI
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
Giuseppe Patti,Vincenzo Pasceri,Giuseppe Colonna,Marco Miglionico,Dionigi Fischetti,Gennaro Sardella,Antonio Montinaro,Germano Di Sciascio +7 more
TL;DR: The ARMYDA-ACS trial indicates that even short-term pretreatment with atorvastatin may improve outcomes in patients with ACS undergoing early invasive strategy, and may support routine use of high-dose statins before intervention in Patients with ACS.
Journal ArticleDOI
Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention: Results From the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) Substudy
Giuseppe Patti,Massimo Chello,Vincenzo Pasceri,Diego Colonna,Annunziata Nusca,Marco Miglionico,Andrea D'Ambrosio,Elvio Covino,Germano Di Sciascio +8 more
TL;DR: In this article, the authors investigated whether protection from myocardial injury during percutaneous coronary intervention (PCI) by atorvastatin is related to reduction of endothelial inflammatory response.
Journal ArticleDOI
Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
TL;DR: To prospectively evaluate the outcome with circulating endothelial progenitor cell (EPC) capture stent implantation in a cohort of consecutive patients with high‐risk angiographic and/or clinical features.
Journal ArticleDOI
Early prediction of contrast-induced acute kidney injury by a "bedside" assessment of Neutrophil Gelatinase-Associated Lipocalin during elective percutaneous coronary interventions.
Annunziata Nusca,Marco Miglionico,Claudio Proscia,Laura Ragni,Massimiliano Carassiti,Francesca Lassandro Pepe,Germano Di Sciascio +6 more
TL;DR: The use of bedside NGAL assessment may significantly hasten diagnosis and treatment of CI-AKI, with remarkable clinical prognostic consequences.
Journal ArticleDOI
Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
Giuseppe Patti,Massimo Chello,Laura Gatto,Gennaro Alfano,Marco Miglionico,Elvio Covino,Germano Di Sciascio +6 more
TL;DR: Reduction of procedural myocardial injury after atorvastatin load is associated with attenuation of endothelial inflammatory response, which may contribute to mechanisms of statin cardioprotection in this setting.